Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations
- PMID: 20383599
- PMCID: PMC2896587
- DOI: 10.1007/s11606-010-1328-7
Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations
Abstract
Background: Fecal occult blood testing (FOBT) is an important option for colorectal cancer screening that should be available in order to achieve high population screening coverage. However, results from a national survey of clinical practice in 1999-2000 indicated that many primary care physicians used inadequate methods to implement FOBT screening and follow-up.
Objective: To determine whether methods to screen for fecal occult blood have improved, including the use of newer more sensitive stool tests.
Design: Cross-sectional national survey of primary care physicians.
Participants: Participants consisted of 1,134 primary care physicians who reported ordering or performing FOBT in the 2006-2007 National Survey of Primary Care Physicians' Recommendations and Practices for Cancer Screening.
Main measures: Self-reported data on details of FOBT implementation and follow-up of positive results.
Results: Most physicians report using standard guaiac tests; higher sensitivity guaiac tests and immunochemical tests were reported by only 22.0% and 8.9%, respectively. In-office testing, that is, testing of a single specimen collected during a digital rectal examination in the office, is still widely used although inappropriate for screening: 24.9% of physicians report using only in-office tests and another 52.9% report using both in-office and home tests. Recommendations improved for follow-up after a positive test: fewer physicians recommend repeating the FOBT (17.8%) or using tests other than colonoscopy for the diagnostic work-up (6.6%). Only 44.3% of physicians who use home tests have reminder systems to ensure test completion and return.
Conclusions: Many physicians continue to use inappropriate methods to screen for fecal occult blood. Intensified efforts to inform physicians of recommended technique and promote the use of tracking systems are needed.
Conflict of interest statement
None disclosed.
Figures
Similar articles
-
A national survey of primary care physicians' methods for screening for fecal occult blood.Ann Intern Med. 2005 Jan 18;142(2):86-94. doi: 10.7326/0003-4819-142-2-200501180-00007. Ann Intern Med. 2005. PMID: 15657156
-
Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007.Am J Prev Med. 2009 Jul;37(1):8-16. doi: 10.1016/j.amepre.2009.03.008. Epub 2009 May 13. Am J Prev Med. 2009. PMID: 19442479 Free PMC article.
-
Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.Am J Gastroenterol. 2018 May;113(5):746-754. doi: 10.1038/s41395-018-0023-x. Epub 2018 Feb 27. Am J Gastroenterol. 2018. PMID: 29487413 Free PMC article.
-
A Comparison of the Cost-Effectiveness of Fecal Occult Blood Tests with Different Test Characteristics in the Context of Annual Screening in the Medicare Population [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2003 Aug 9. Rockville (MD): Agency for Healthcare Research and Quality (US); 2003 Aug 9. PMID: 25905156 Free Books & Documents. Review.
-
[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Gastroenterol Hepatol. 2009. PMID: 19577340 Review. Spanish.
Cited by
-
Patterns of Care Following a Positive Fecal Blood Test for Colorectal Cancer: A Mixed Methods Study.J Gen Intern Med. 2024 May 21. doi: 10.1007/s11606-024-08764-0. Online ahead of print. J Gen Intern Med. 2024. PMID: 38771535
-
Risk of colorectal cancer in patients with positive results of fecal immunochemical test performed within 5 years since the last colonoscopy.Korean J Intern Med. 2021 Sep;36(5):1083-1091. doi: 10.3904/kjim.2020.525. Epub 2021 Jun 18. Korean J Intern Med. 2021. PMID: 34134468 Free PMC article.
-
Patient Navigation After Positive Fecal Immunochemical Test Results Increases Diagnostic Colonoscopy and Highlights Multilevel Barriers to Follow-Up.Dig Dis Sci. 2021 Nov;66(11):3760-3768. doi: 10.1007/s10620-021-06866-x. Epub 2021 Feb 20. Dig Dis Sci. 2021. PMID: 33609211
-
Factors to Improve Endoscopic Screening for Colorectal Cancer.J Gastrointest Cancer. 2021 Mar;52(1):289-293. doi: 10.1007/s12029-020-00402-2. J Gastrointest Cancer. 2021. PMID: 32303997
-
Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.Cancer Med. 2019 Dec;8(17):7408-7418. doi: 10.1002/cam4.2604. Epub 2019 Oct 21. Cancer Med. 2019. PMID: 31637870 Free PMC article.
References
-
- Eddy D. American Cancer Society report on the cancer-related health checkup. CA Cancer J Clin. 1980;30:193–240. - PubMed
-
- U.S. Preventive Services Task Force . Guide to Clinical Preventive Services. 2. Alexandria, VA: International Medical Publishing; 1996.
-
- Byers T, Levin B, Rothenberger D, Dodd GD, Smith RA. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin. 1997;47:154–60. doi: 10.3322/canjclin.47.3.154. - DOI - PubMed
-
- U.S. Preventive Services Task Force Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002;137:129–31. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
